The immune response to an antigen can be classified as humoral (antibody based) or cell mediated. Both processes require lympho- cytes and antigen-presenting cells (APCs), which may be lymphocytes, macrophages, or dendritic cells. Lymphocytes are de- scribed as B cells or T cells, a naming con- vention based on the site of their original differentiation—bone marrow (B cells) or thymus (T cells).5
Humoral immunity occurs through B cells, which produce soluble, membrane- bound immunoglobulin (antibody) for a spe- cific antigen. Cell-mediated immunity occurs through T cells that recognize an antigen when it is bound to a major histocompatibility complex (MHC) molecule, also termed a human leukocyte antigen (HLA). Thus, B cells are frequently the APCs to the T-cell receptors. Binding of the APCs with the T-cell receptors stimulates division of T cells into one of two types of helper cells (Th1 or Th2) and secretion of numerous cytokines that in- duce an inflammatory response (Fig. 3).
There are two classes of MHC molecules (class I and II), both of which contain a large number of alleles (variable regions). Although MHC molecules bind antigens, they differ from B-cell receptors in that MHC molecules are expressed by a number of cell types. They also lack the specificity of the antibodies produced by B cells. Several chronic inflammatory diseases, such as RA, are associated with distinct alleles that may confer genetic predisposition to the disease. That the inflammation persists or recurs in these chronic diseases indicates that at- tempts to achieve homeostasis are impeded, possibly by a recurrent trigger.